Recent Study Reinforces the Benefits of Omega-3 Fatty Acids For Women

Pronova Biocare Continues to Emphasize The Importance of Omega-3s for Women

LYSAKER, Norway, October 27, 2004 -- A new study published in the October 2004 issue of Obstetrical & Gynecological Survey, concluded that women in particular gain from an increased intake of omega-3 fatty acids. The study reaffirms Pronova Biocare's (one of the largest fish oil producers in the world and makers of EPAX® Omega-3 fish oils) research concluding the importance of omega-3s for women's general health.

"As omega-3s play an essential role in human health, new scientific studies are constantly reinforcing their benefits," stated Morten Bryhn, M.D., Ph.D., director of research and development for Pronova Biocare, makers of EPAX® Omega-3 fish-oils. "We have been studying the benefits of omega-3s for women for years. Studies like these further support our efforts to educate consumers, especially women, about the ongoing benefits of omega-3s."

The objective of the study was to investigate the role of omega-3 fatty acids and their affect on the prevention and treatment of health problems unique to women. They found evidence that supplementation with omega-3 fatty acids might help to prevent preeclampsia, postpartum depression, menopausal problems, postmenopausal osteoporosis and breast cancer, among others. The study did note that they only used high quality omega-3 fatty acids to determine these results.

The health benefits of marine omega-3 fatty acids are increasingly being accepted worldwide. The scientific evidence continues to mount, representing an opportunity for the treatment and prevention of common diseases. The American Heart Association and the World Health Organization both support the addition of omega-3 fatty acids to diets citing their importance in maintaining good health.

At Pronova Biocare, each and every production run of omega-3 carries full quality control documentation to ensure that the highest quality standards are maintained. Chemical analyses take place at every crucial stage and the most stringent, hygienic conditions are applied throughout Pronova Biocare operations. EPAX products are produced in Pronova's GMP facilities to meet the highest possible quality standards. The products also comply with the CRN voluntary monograph.

Pronova Biocare, headquartered in Lysaker, Norway, has two GMP approved production facilities: one located in Sandefjord that is qualified by the US Food and Drug Agency for producing omega-3 pharmaceuticals and the second located in Alesund. Pronova Biocare offers omega-3 EPA/DHA oils in the B2B segment under the brand name EPAX. EPAX is available in a wide range of top quality products with different EPA/DHA ratios.

For further information on Pronova Biocare, EPAX products and clinical studies visit or contact Tiia Sumera at 801.538.0777 ext. 112 or [email protected].

Tiia Sumera
Integrated Marketing Group
801.538.0777 ext. 112
[email protected]

Obstet Gynecol Surv. 2004 Oct;59(10):722-730. Saldeen P, Saldeen T.
*Researcher, Department of Obstetrics and Gynecology, Malmo University Hospital, University of Lund, Sweden; and the daggerProfessor, Department of Surgical Sciences, University of Uppsala, Sweden.

European Food Safety Authority

J Epidemiol Community Health 2004; 58: 486-492. Maternal fish intake in late pregnancy and the frequency of low birth weight and intrauterine growth retardation in a cohort of British infants, I Rogers, P Emmett, A Ness, and J Golding,

PMID: 15385858 [PubMed - as supplied by publisher]

Full text link

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.